SKIN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Skinhealth Systems Inc (SKIN) is not a strong buy at the moment for a beginner investor with a long-term focus. The financial performance shows declining revenue, net income, and EPS, while technical indicators suggest a bearish trend. Options data indicates bearish sentiment with a high put-call volume ratio. Additionally, there are no recent positive news catalysts or significant insider/congress trading activity to support a buy decision.
The MACD is slightly positive but contracting, indicating weak momentum. RSI is neutral at 29.307, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its S1 support level of 0.846, with resistance at 0.912. Overall, the technical indicators suggest a bearish trend.
Hedge funds are significantly increasing their buying activity, with an 87233.33% increase in the last quarter. Gross margin improved by 5.92% YoY in Q4 2025.
Analysts have lowered the price target to $1.50 from $1.65, maintaining a Hold rating. Options data shows bearish sentiment with a high put-call volume ratio of 4.0.
In Q4 2025, revenue dropped by -1.35% YoY to $82.37M, net income fell by -21.55% YoY to -$8.10M, and EPS declined by -25.00% YoY to -0.06. However, gross margin increased to 73.13%, up 5.92% YoY.
TD Cowen lowered the price target to $1.50 from $1.65 and maintained a Hold rating. While FY26 EBITDA guidance suggests potential upside, macroeconomic pressures are affecting distributor ordering, leading to a softer Q1 outlook.
